Pacifica Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
Pacifica Partners's ABCL Position: Q3 2026 in Review
Pacifica Partners held its AbCellera Biologics (ABCL) position steady in Q3 2026 at 2,230 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #207.
Pacifica Partners first reported a position in ABCL in Q4 2020 and has held it in 24 quarters since. The position peaked at $51K in Q3 2021. 15 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- Pacifica Partners held 2,230 shares of AbCellera Biologics worth $31K as of Q3 2026.
- Pacifica Partners left its AbCellera Biologics share count unchanged in Q3 2026.
- AbCellera Biologics made up 0.01% of Pacifica Partners's portfolio in Q3 2026, its #207 holding.
- Pacifica Partners first reported a position in AbCellera Biologics in Q4 2020 and has held it in 24 quarters since.
- Pacifica Partners's AbCellera Biologics position peaked at $51K in Q3 2021.
- 15 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.